5-HT2C agonism as a neurotherapeutic for sarcopenia: preclinical proof of concept.
Kerr NR, Dashtmian AR, Darvishi FB, Brennan CD, Ayyagari SN, Moore PJ, Viteri JA, Wang M, Rich MM, Clark BC, David Arnold W.
Kerr NR, et al. Among authors: wang m.
Geroscience. 2025 Jan 17. doi: 10.1007/s11357-025-01519-7. Online ahead of print.
Geroscience. 2025.
PMID: 39825167